Chest PNF on Pulmonary Function in Parkinson Disease

Parkinson Disease Clinical Trial

Official title:

Efficacy of Chest PNF on Pulmonary Function in Patients With Parkinson's Diseases

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03977740
• Other study ID #: IEC-1111
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2018
• Est. completion date: June 10, 2019

Study information

• Verified date: June 2019
• Source: Maharishi Markendeswar University
• Contact: Mousumi Saha, MPT
• Phone: 9366787310
• Email: msaha0029[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Background: Parkinson disease (PD) is a progressive neurodegenerative disorder and characterized by tremor, rigidity and bradykinesia. Almost 84% of PD patient develops respiratory abnormalities and pointed as the most common cause of death. Airway obstruction, trunk muscle rigidity is the common cause of respiratory abnormalities.

Purpose: The main purpose of the study will evaluate the efficacy of chest PNF on pulmonary function and chest wall mobility in PD.

Methods: 20 participants will be recruited for study purpose and divide into two groups. Group= A will be the control group and participants will receive conventional treatment which includes deep breathing exercise and segmental breathing exercise, incentive spirometry etc for one week. Group= B participants will receive chest PNF exercise along with conventional treatment for a week. Pretreatment and post-treatment data will be recorded by the help of PFT (FVC, FEV1 & FEV1/FVC) and chest wall expansion at axillary and xiphisternal level for data analysis. Data analysis will be done by paired t-test for within group and independent t-test will be used for the between-group variable. The level of significance will be set at 0.05.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: June 10, 2019
• Est. primary completion date: June 10, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years to 70 Years

Eligibility

Inclusion Criteria:

1. Grade 3 to grade 5 Parkinson patients according to Hoehn Yahar scale

2. MMSE score >23.

3. Age 50-70 yrs.

4. Both Male and Female.

Exclusion Criteria:

1. Previous history of cardiac and pulmonary surgery.

2. History of flail chest.

3. Individual affected by neurological disorder other than PD.

4. Uncooperative patients.

5. Individual with the psychosomatic disorder.

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Other:
• chest PNF
Chest PNF technique includes oblique downward pressure at sternum, diagonal pressure at lower rib cage at supine line, caudal medial pressure at side lying, Caudal pressure at ribcage at prone lying, dorsal and caudal pressure at prone on elbow.
• Conventional
conventional chest physiotherapy treatment, which includes Deep breathing exercise, Diaphragmatic breathing exercise, segmental breathing exercise and purse lip breathing and incentive spirometer

Locations

Country	Name	City	State
India	MMIPR	Ambala	Haryana

Sponsors (1)

Lead Sponsor	Collaborator
Subhasish Chatterjee

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pulmonary Function Test (PFT)	Pulmonary functions parameters FVC in litre, FEV1 in litre and ratio between FVC/FEV1 will be recorded with PFT	changes bwtween baseline to 1 week
Secondary	chest wall expansion by inch tape	chest wall expansion will be measured at axillary and xiphisternal level	changes bwtween baseline to 1 week